AkzoNobel appoints new investor relations director
August 25, 2011Sales and Marketing appointment, sales and marketing
Jonathan Atack is set to join AkzoNobel as the company’s new corporate director of investor relations. He was most recently …
Market access and the new NHS in England
August 25, 2011Sales and Marketing NHS, NHS reforms
The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …
Sharp increase in NHS diabetes prescribing costs
August 25, 2011Sales and Marketing GP prescribing, NHS, diabetes, prescribing
NHS prescribing for diabetes has risen sharply, largely driven by the disease’s growing prevalence in the UK. Spending rose 41% …
NICE says no to BMS for second-line Orencia
August 25, 2011Sales and Marketing BMS, NICE, Orencia, rheumatoid arthritis
In final draft guidance NICE has not recommended the use of Bristol-Myers Squibb’s arthritis drug Orencia after other drugs have …
inVentiv Health consolidates Europe agencies
August 25, 2011Medical Communications inVentiv Health, medical communications news
Communications group inVentiv has launched a new company which brings together all of its healthcare services under one roof. inVentiv …
FDA approves Botox to treat urinary incontinence
August 25, 2011Sales and Marketing Allergan, Botox, urinary incontinence
Botox has been approved in the US to treat urinary incontinence as manufacturer Allergan continues to expand the brand’s non-cosmetic …
Clinical research news in brief
August 24, 2011Research and Development contract research news, research and development news
Private equity firm the Carlyle Group is rumoured to be looking at buying PPD, plus there are updates from CTA/Clininvent, …
AZ details US doctor payments
August 24, 2011Sales and Marketing AstraZeneca, industry reputation, payments
AstraZeneca is shining a light on its activities in the US, disclosing for the first time how much it pays …
Spain to cut 2.4 billion euros from drugs bill with new generics rules
August 24, 2011Sales and Marketing Spain, generic prescribing, generics
The Spanish government has passed new laws to increase generic prescribing and cut billions of euros from the country’s drugs …
Blood cancer drug Adcetris approved by FDA
August 24, 2011Sales and Marketing Adcetris, Cancer, Seattle Genetics, lymphoma
The FDA has approved Seattle Genetics’ blood cancer drug Adcetris for two forms of lymphoma. Adcetris (brentuximab vedotin) can now …
Quintiles appoints Troy Norris to head up consulting group
August 24, 2011Research and Development appointment, research and development
Troy Norris has joined Quintiles as vice president and managing director for the product development and commercialisation practice at its …
UK research receives £800m funding boost
August 23, 2011Research and Development NIHR, UK research, UK science, research and development news
Research into dementia, cancer, diabetes and heart disease are among the activities to benefit from a new £800 government funding …
Zaicom Medical Marketing Communications appoints Ana Gaskill
August 23, 2011Medical Communications appointment, medical communications
Zaicom Medical Marketing Communications (Zaicom MMC) has appointed Ana Gaskill as an account director. She joins the West Sussex, UK-based …
Healthcare communications – how to influence behaviour change
August 23, 2011Medical Communications communications, healthcare communications
For decades, healthcare communications has used a fixed way of approaching patients and customers. But now we must adopt new …
FDA fast tracks Bayer prostate cancer drug
August 23, 2011Sales and Marketing Algeta, Alpharadin, Bayer, prostate cancer
Bayer’s potential blockbuster prostate cancer drug Alpharadin has been granted a fast track review by the FDA, meaning it could …
NICE blames Faslodex rejection on uncertainties in AZ data
August 23, 2011Sales and Marketing AstraZeneca, Faslodex, NICE, breast cancer
NICE has not recommended a high-dose form of AstraZeneca’s breast cancer drug Faslodex because of uncertainties over its cost-effectiveness. In …
GSK invests in UK biotech start-up
August 22, 2011Research and Development Autifony, GSK, biotech, hearing loss, research and development news
GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …
Generic user fees could boost FDA inspection powers
August 22, 2011Manufacturing and Production Mylan, generics, pharma manufacturing news
Generic drugmakers have forged a tentative deal with the US government that could see user fees being used to help …
BMS launches skin cancer treatment Yervoy in UK
August 22, 2011Sales and Marketing Yervoy, cancer vaccine, ipilimumab, skin cancer
Bristol-Myers Squibb’s skin cancer treatment Yervoy has been launched in the UK for patients with the deadliest form of the …
Double Helix expands strategic market research team
August 22, 2011Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing
Global market research consultancy Double Helix has appointed Fiona Bailey and Anwar Kumi to the positions of associate director and …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
